📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tranexamic Acid for Trauma Patients - More Lives to Save and Outcomes to Consider. (2023)

First Author: Shakur-Still H

Attributed to: The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejme2305075

PubMed Identifier: 37314242

Publication URI: http://europepmc.org/abstract/MED/37314242

Type: Journal Article/Review

Volume: 389

Parent Publication: The New England journal of medicine

Issue: 2

ISSN: 0028-4793